Hepatic Artery Infusion Pump for NPC Liver Metastases
Status:
Completed
Trial end date:
2017-12-31
Target enrollment:
Participant gender:
Summary
A retrospective clinical trial to study the safety and effectiveness of hepatic arterial
infusion (HAI) in treating patients who have nasopharyngeal carcinoma metastatic to the
liver. Hepatic-direction drug administration improves the control power for intra-hapatic
lesions.